Remdesivir Has ‘No Significant Effect’ on Ventilator COVID-19 Patients: Study

Remdesivir Has ‘No Significant Effect’ on Ventilator COVID-19 Patients: Study
A lab technicians holds the COVID-19 treatment drug Remdesivir at Eva Pharma Facility in Cairo, Egypt, June 25, 2020. Amr Abdallah Dalsh/Reuters
Jack Phillips
Updated:

Remdesivir has little effect on hospitalized COVID-19 patients who are on ventilators, according to results from a World Health Organization-backed (WHO) randomized trial and analysis.

The results, published in The Lancet (pdf), evaluated 14,221 patients from 454 hospitals in 35 countries, including 8,275 who were randomly assigned to receive up to 10 daily infusions of remdesivir or a control drug between March 2020 and January 2021—coming before the emergence of the Delta and Omicron COVID-19 variants.
Jack Phillips
Jack Phillips
Breaking News Reporter
Jack Phillips is a breaking news reporter who covers a range of topics, including politics, U.S., and health news. A father of two, Jack grew up in California's Central Valley. Follow him on X: https://twitter.com/jackphillips5
twitter
Related Topics